Victor Leach of ORSAA: Critical review of the FDA 2020 Report
Published on Dariusz Leszczynski’s website
Below is the next in a series of Guest Blogs on BRHP. The opinions expressed in this Guest Blog are of Victor Leach himself. Publication of these opinions in BRHP does not imply that BRHP automatically agrees with or endorses these opinions. Publication of this, and other guest blogs, facilitates an open debate and free exchange of opinions on wireless technology and health.
***********************
Read also BRHP own post on FDA 2020 Report:
US FDA 2020 Report on carcinogenicity of RF-EMF contradicts safety claims of ICNIRP
***********************
Excerpt from Victor Leach’s FDA analysis:
Comment on the FDA 2020 Report
“˜Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer”™
by Victor Leach
ORSAA “” Oceania Radiofrequency Scientific Advisory Association
The FDA is responsible for protecting and promoting public health through the control and supervision of many consumer products, drugs, vaccines, medical devices, electromagnetic radiation etc. They have a responsibility to protect consumers from biotoxins, and hence this FDA review of wireless radiation.
As outlined below I believe this report is inadequate and biased in favour of industry. The following revelations that emerged from my analysis of this report in detail will explain why I have come to this conclusion….SNIP
*******************************************************
Leave a reply →